期刊文献+

奥司他韦、利巴韦林和盐酸金刚乙胺对甲型H1N1流感病毒的抑制作用 被引量:12

Antiviral Activity of Oseltamivir Phosphate,Ribavirin and Rimantadine Hydrochloride on Influenza A/H1N1 Virus in Vitro
下载PDF
导出
摘要 目的细胞水平测试奥司他韦、利巴韦林和盐酸金刚乙胺对甲型流感H1N1病毒的抑制或杀伤作用。方法通过在MDCK细胞系和甲型H1N1病毒株间建立药物剂量-效应关系确定导致细胞死亡的效力与抑制病毒复制的效力的比值(治疗指数),测试药物的抗病毒效果。结果奥司他韦、利巴韦林和盐酸金刚乙胺对MDCK细胞的半数中毒浓度分别为(1134.7±186.8)μg/mL、(742.0±76.9)μg/mL、(94.6±1.9)μg/mL,对甲型H1N1病毒的治疗指数(TI)分别为71.19、24.9和3.12。结论奥司他韦对甲型H1N1病毒抑制作用最强,利巴韦林其次,盐酸金刚乙胺对甲型H1N1病毒抑制效果较弱。 Objective To evaluate the antiviral activity of oseltamivir phosphate,ribavirin and rimantadine hydrochloride on influenza A(H1N1) in vitro.Methods Drugs diluted in FCS-free DMEM media supplemented with 2 μg/ mL TPCK-treated trypsin was applied to confluent MDCK cell monolayers for 1 h prior to addition of virus,at a challenge dose of one hundred times of the TCID50.The IC50 of drugs were calculated using neutral red assay after 3 days treatment at 34℃.Results The therapeutic index(TI) of oseltamivir phosphate against influenza A(H1N1) virus was 61.90,ribavirin was 42.86,and rimantadine hydrochloride was 6.22.Ubenimex was lower than 1.00.Conclusions Influenza virus is sensitive to oseltamivir phosphate and ribavirin.The antiviral effect of rimantadine hydrochloride is significantly lower than that of oseltamivir phosphate and ribavirin.
出处 《中国比较医学杂志》 CAS 2011年第2期23-25,共3页 Chinese Journal of Comparative Medicine
基金 北京市科技计划课题 编号:Z09000700090904
关键词 病毒 甲型H1N1 奥司他韦 利巴韦林 盐酸金刚乙胺 Influenza A(H1N1) virus Oseltamivir phosphate Ribavirin Rimantadine Hydrochloride
  • 相关文献

参考文献9

  • 1Dharan NJ; Gubareva LV; Meyer JJ,et al.Infection with oseltamivir-resistant influenza A (H1N1) virus in the United States[J].JAMA,2009,301(10):1034-1041.
  • 2Eriksson B,Helgstrand E,Johansson NG,et al.Inhibition of influenza virus riboncleic acid polymerase by ribavirin triphosphate[J].Antimicrob Agents Chemoth,1977,p.946-951.
  • 3高长有.盐酸金刚乙胺防治流行性感冒的疗效分析[J].临床心身疾病杂志,2007,13(5):442-442. 被引量:2
  • 4Rohloff J C,Kent K M,Postich M J,et al.Practical total synthesis of the anti-influenza drug GS-4104[J].Org Chem,1998,63(13):4545-4550.
  • 5Neumann G,Noda T,Kawaoka Y.Emergence and pandemic potential of swine-origin H1N1 influenza virus[J].Nature,2009,459:931-939.
  • 6Soundararajan V,Tharakaraman K,Raman R,et al.Extrapolating from sequence-the 2009 H1N1"swine"influenza virus[J].Nat Biotechnol.2009,27:510-513.
  • 7Chen Z,Wang W,Zhou H,et al.Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs[J].J Virol.2010,84(1):44-51.
  • 8新药(西药)临床及临床前研究指导原则[S].中国人民共和国卫生部药政局.1993:170-171.
  • 9国家食品药品监督管理局国家药品标准[S].WS1-(X-251)-2004Z.

二级参考文献3

共引文献1

同被引文献86

引证文献12

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部